Abstract: Polyphenols (PPH) are a group of chemical substances found in plants, characterized by the presence of more than one phenol unit . The largest and best studied polyphenols are the fl avonoids, which include several thousand compounds. PPH are the most abundant antioxidants in human diets. Their sheer mass in the diet exceeds that of the consumed vitamins. The Mediterranean diet is rich in PPH because it contains abundant vegetables, fruits, unrefi ned cereals, legumes, nuts, garlic, olive oil and red wine. Locations where the Mediteranean diet prevails are known for a reduced premature cardiovascular disease (CVD) mortality. However, this geographic distinction is not entirely unique. Low CVD mortality is also present in countries with high consumption if plant food and fi sh, as Scandinavia, Switzerland and Austria. Putative mechanisms of the metabolic effect of PPH are related to multiple biologic functions that may have benefi cial effect in the prevention of some infl ammation-mediated disorders, including CVD. Naturally occurring dietary PPH can directly scavenge free oxygen radicals, adhesion molecules, and growth factor receptor genes. Thus, these polyphenolic compounds have potential therapeutic value as antioxidant and anti-infl ammatory agents in CVD. PPH reduce the generation of oxidized low density lipoproteins (LDL), induce nitric oxide (NO) production, inhibit platelet aggregation and downregulate expression of proinfl ammatory mediators (Fig. 6, Tab. 1, Ref. 33). Full Text in PDF www.elis.sk.
Nutrition sciences in the fi rst decades of the twentieth century became preoccupied with protective nutrients labelled as vitamins. These were attributed to organic compounds that the body is unable to synthetize, so they have to be provided in the food. Their insuffi cient supply leads to defi ciency (hypo-or avitaminosis) that may result in disease or even death. Such vitamin concept does not include other essential nutrients such as minerals, essential amino acids and fatty acids, nor does it encompass the large number of other nutrients that promote health.
Polyphenols (PPH) rank among nutrients having an important potential for maintaining health. The largest and best studied PPH are the fl avonoids, which include several thousand compounds, among them the fl avonols, fl avones, catechins, fl avanones, anthocyanidins, and isofl avonoids. Nutritional defi ciency of fl avonoids is not equivalent to "avitaminosis" although it is associated with a negative impact on health.
Dietary fl avonoids represent a wide variety of compounds that occur in vegetables, fruits, legumes, nuts, cereals, wine, tea, virgin olive oil and cocoa products. Presently there are over 8,000 structural variants of fl avonoids, bearing aromatic rings and one or more hydroxyl moieties. In the past few years fl avonoids have been very much in biomedical focus. PubMed refers to over 52,000 papers dealing with the subject of fl avonoids.
The reader interested in more details on the subclasifi cation and chemical structure of PPH may fi nd ample additional information (1, 2) . The aim of this review is to bring attention only to PPH that have the most promising potential in assisting with prevention of cardiovascular disorders.
Polyphenols and cardiovascular disease
Phenols are a class of chemical compounds consisting of a hydroxyl group (-OH) bonded directly to an aromatic hydrocarbon group. Phenol forms a redox system with chinone ( Fig. 1 ) and therefore dietary PPH can directly scavenge free oxygen radicals and downregulate expression of proinfl ammatory mediators, adhesion molecules, and growth factor receptor genes. Thus, these polyphenolic compounds have potential therapeutic value as antioxidant and anti-infl ammatory agents in CVD.
Oxidation of phenol to chinone Phenol Chinone Potential evidence for health benefi t of dietary PPH is the relatively low CVD mortality in geographic regions where the population consumes a diet high in fruit, vegetables and other plant food (3) . In addition to direct effect of PPH on metabolic processes leading to lipid deposition in the arterial wall, there are other, until recently little explored venues where PPH may decrease predisposition to CVD. Low CVD in southern Europe, in France, Italy and Spain may also be related to other factors of the life style, especially the emotional well being (4). Recent years have brought solid scientifi c evidence for a direct association between severe depression and the atherogenesis (5, 6) . Cerebral blood fl ow must be maintained to ensure a constant delivery of oxygen and glucose as well as the removal of waste products. The prospect for increasing blood fl ow with dietary polyphenols is extremely promising (7) . The high demand of brain for molecular oxygen, high level of polyunsaturated fatty acids in membrane phospholipids and low activity of antioxidant defense enzymes are factors rendering cells in the central nervous system particularly vulnerable to oxidative stress.
This review by no means pretends to analyze the effect of all PPH on the CV system: such account would be too wide. The focus is only on the most relevant PPH that have been defi nitely confi rmed to bear a favorable effect on metabolic pathways which link to the CV system.
Resveratrol
Although resveratrol was fi rst isolated in 1940, the importance of resveratrol was recognized only after the widely publicized "French Paradox" associated with drinking of red wine. Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin (Fig.  2) . It is produced in the skin of grapes by the effect of fungi and bacteria. Resveratrol is also present in many other plant products. The highest concentrations of resveratrol are found in red Spanish wines (over 12 mg/L). Experimental studies have provided evidence that resveratrol possesses antioxidant (oxidative modifi cation of LDL),antiapoptotic, angiogenic, antihypercholesterolemic, and antidiabetic effects. Exposure to resveratrol stimulates nitric oxid (NO) production, protects endothelial cells from oxidative functional damage, also affects the antiplatelet activity and mononucleocyte adhesion (8, 9, 10, 11) .
In humans, resveratrol, at the concentrations produced in plasma by moderate intake of wine, stimulated in platelets NO production and lowered platelet aggregation ( Fig. 3) (12) . Resveratrol may hold promise in the management of myocardial ischemia and ox-LDL-hypercholesterolemia. Resveratrol seems to be well tolerated and no marked toxicity was reported. These data are important in the context of human effi cacy studies, and they provide further support for the use of resveratrol as a pharmacological drug in human medicine (12, 13) . Resveratrol likely fulfi lls the defi nition of a pharmacological preconditioning compound and gives hope for the therapeutic promise of alternative medicine (14) .
Enterolactone
This interesting PPH differs from other PPH in that it is not derived directly from food but that it is generated in the colon by the activity of intestinal microorganisms which affect plant lignans. Resulting enterolactone is not only an important biomarker of dietary intake of vegetables and dietary fi ber but its phenolic structure is also an important antioxidant (Fig. 4) . There are reports associating high levels of enterolactone with reduced risk of coronary heart disease and cardiovascular disease mortality (Fig. 5 ) (15) . High intake of fresh fruit, root vegetables, cereals and fruiting vegetables was associated with reduced mortality of coronary heart disease and stroke in a prospective study on more than 40,000 males and females in Spain and in many other countries (16) .
Curcumin
Curcumin is a yellow-colored polyphenolic pigment obtained from the rhizome of Curcuma longa Linn. The root of turmeric has long been used in traditional Asian medicine. Animal experiments demonstrated anti-infl ammatory, antioxidant, and anti-cancer properties of curcumin (17) . In animal models curcumin ameliorates the development of cardiac hypertrophy and heart failure (18). Curcumin was found to be much faster in terms of quenching free oxygen radicals when compared to resveratrol or quercetin. Curcumin has been demonstrated to induce antioxidant defenses through increase in glutathione production. The anti-thrombotic, anti-proliferative, and anti-infl ammatory effects of curcumin and the effect of curcumin in decreasing the LDL-cholesterol level may protect against the pathological changes occurring with atherosclerosis.
Initially it was postulated that curcumin cannot be absorbed from the human gastrointestinal tract. More recently it was reported that curcumin is absorbed after oral dosing in humans and can be detected as glucuronide and sulfate conjugates in plasma (19) . Preliminary human evidence suggests possible effi cacy of curcumin in the management of heart disease (20) . Further clinical trials are needed to fully develop the potential of curcumin.
Sources of polyphenols -problem of dietary supplements
Intensive interest in PPH dates back more than ten years. This has also been refl ected in a remarkable commercial response of the dietary supplement industry, of the alternative medicine establishment, along with vigorous marketing. Dietary supplements are based on the assumption that dietary sources of essential nutrients do not provide adequate protection and protective substances have to be administered in a non-dietary form.
Such a suggestion is questionable. Individuals consuming adequate amount of plant diet, receive in their diet large and variable sources of PPH.
Fruits such as grapes, pears, apples, plums, raspberries, blackberries, blueberries, cantaloupe, cherries, cranberries, pears and strawberries, most legumes and vegetables such as cabbage, celery, onion, broccoli and parsley are rich in PPH. Many grains, red wine, chocolate, green tea and olive oil are also rich sources of PPH. This is why the role of dietary supplements as a method of realizing health benefi ts of PPH is the subject of considerable discussion.
Enormous amount of money is spent on products that have not been approved by the controlling agencies that decide on the basis of scientifi c evidence (e.g. FDA, Food and Drug Administration in the USA). Remarkably, after more than ten years there has been no decisive ruling on the health effi cacy, safe dose and absence of side effects of the PPH. Because of uncertainty about the metabolic effi ciency of PPH, a dietary reference intake for PPH has not been established (21) . To obtain scientifi c validity of health benefi ts of PPH, adequate data on the bioavailability, dose effect and toxic levels have to be established. Structural difference in the large number of PPH makes it diffi cult to study their biological effect and to set daily recommended doses for at least the most important PPH.
Resveratrol, one of the most prominent PPH is a good example. Words of caution include its potential side effects: there is a mild hormonal effect, estrogenic and anti-growth (the product should not be used in small children). Resveratrol reduces the activity of some enzymes involved in the metabolism of medications. Because of its potential anti-platelet effect, it has to be used with caution in patients who take blood thinners.
Conclusion
The large group of plant PPH includes more than ten subclasses. What concerns the antioxidant capacity of human diet, the contribution of PPH is much larger than that of the vitamins. Flavonoids, the water-soluble plant pigments are the most important group of PPH and their total intake could amount to almost 1 g/d, much higher than the intake of all dietary vitamins with antioxidative effect (21) (Tab. 1). This review confi rms the accumulating evidence that PPH possess a diverse array of biological actions and may be benefi cial in the prevention of some infl ammatory-mediated diseases including cardiovascular disease. Unfortunately, at this time, no randomized controlled trial studied effects of PPH on CVD.
However, meta analyses of prospective studies indicate that high dietary intake of fl avonols may be associated with a reduced risk from CVD in free-living populations (22) (23) (24) (25) (26) . A number of trials of acceptable quality with fl avonoid-rich foods provide evidence for a benefi cial effect on fl ow-mediated dilation, blood pressure and lipid profi le, which are relevant indicators of cardiovascular health. Optimal doses of specifi c fl avonoids for CVD protection are not known, but there are new data from 2010 on the protective effects of berries (chokeberries, cranberries, blueberries, and strawberries) such as upregulation of endothelial nitric oxide synthase, decreased activities of carbohydrate digestive enzymes, decreased oxidative stress, and inhibition of infl ammatory gene expression and foam cell formation (27) . Benefi ts were seen in healthy subjects and in those with existing metabolic risk factors. The results with pomegranate juice are promisimg: this juice signifi cantly reduced atherosclerotic lesion areas in immune-defi cient mice and intima media thickness in cardiac patients. It also decreased lipid peroxidation in patients with type 2 diabetes, and systolic blood pressure and serum angiotensin converting enzyme activity in hypertensive patients (28) . There is an increasing body of evidence that fl avonoids specifi cally target molecular structures including cardiovascular ion channels (29) .
Red wine polyphenols are able to activate extracellular regulated kinase and p38 kinase and switch off the NF-kappaB pathway via an increased expression with time of the IkappaBalpha (IκB-alfa) phosphorylated form (30) . These mechanisms may represent key molecular events leading to inhibition of the proinfl ammatory cascade and atherogenesis. PPH have the capacity to improve the endothelial control of vascular tone not only in several experimental models of cardiovascular diseases such as hypertension but also in healthy and diseased humans (31) . The experiments on healthy people indicate a signifi cant role of olive oil polyphenols in the down-regulation of proatherogenic genes. The benefi ts associated with olive oil polyphenol consumption on cardiovascular risk can be mediated through nutrigenomic effects (32) . Figure 6 summarizes the bioactivities of PPH with the resulting cardioprotective effects.
The supplementation of cardiovascular friendly natural products needs to be considered in all populations who have high prevalence of CVD. Although PPH-rich foods are likely to protect cardiovascular system, long-term clinical trials are needed to defi nitively clarify the benefi ts deriving from long-term consumption of PPH-rich foods, particularly focusing on the lowest effective levels as well as synergism or antagonistic actions between different classes of PPH (33 
